다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Regenerative biomaterials, v.3 no.2, 2016년, pp.99 - 105
Li, Ling (Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China) , He, Zhi-Yao (Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China) , Wei, Xia-Wei (Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China) , Wei, Yu-Quan (Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China)
AI-Helper
Biotherapy mainly refers to the intervention and the treatment of major diseases with biotechnologies or bio-drugs, which include gene therapy, immunotherapy (vaccines and antibodies), bone marrow transplantation and stem-cell therapy. In recent years, numerous biomaterials have emerged and were uti...
1 Thorne SH Negrin RS Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy . Science 2006 ; 311 : 1780 – 4 . 16556847
2 Gretch D. Advocating the concept of GB virus C biotherapy against AIDS . Clin Infect Dis 2012 ; 55 : 1020 – 21 . 22752513
3 Naji A Rouas ‐Freiss N. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy . Stem Cells 2013 ; 31 : 2296 – 303 . 23922260
4 van Rooij E Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles . Nat Rev Drug Discov 2012 ; 11 : 860 – 72 . 23080337
5 Jieheng W Angang Y Weihong W. Current status of bench-to-bedside translation of cancer therapeutic antibodies . Chin J Cancer Biother 2014 ; 3 : 023 .
6 Abdelbary H Brown CW Werier J Using targeted virotherapy to treat a resistant ewing sarcoma model: from the bedside to the bench and back . Sci World J 2014 ; 2014 : 171439 .
7 Uckun FM. Monoclonal antibody (mAb)-based biotherapy options for b-lineage non-Hodgkin’s lymphoma (NHL) . Trans Med 2013 ; 3 : e118 .
8 Chen X Lin X Zhao J A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs . Mol Ther 2008 ; 16 : 749 – 56 . 18362930
9 Su X Zhang L Jin L Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma . Cancer Biother Radiopharm 2010 ; 25 : 465 – 70 . 20701541
10 Niidome T Huang L. Gene therapy progress and prospects: nonviral vectors . Gene Ther 2002 ; 9 : 1647 – 52 . 12457277
11 Rosenberg SA. Progress in human tumour immunology and immunotherapy . Nature 2001 ; 411 : 380 – 4 . 11357146
12 Segers VF Lee RT. Stem-cell therapy for cardiac disease . Nature 2008 ; 451 : 937 – 42 . 18288183
13 Huang X Liu D Liu K Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies . Bone Marrow Transpl 2006 ; 38 : 291 – 7 .
14 Kim SU De Vellis J. Stem cell‐based cell therapy in neurological diseases: a review . J Neurosci Res 2009 ; 87 : 2183 – 200 . 19301431
15 Childs R Chernoff A Contentin N Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation . N Engl J Med 2000 ; 343 : 750 – 8 . 10984562
16 Swami A Shi J Gadde S. Nanoparticles for targeted and temporally controlled drug delivery In: Svenson S Prud’homme RK (eds). Multifunctional Nanoparticles for Drug Delivery Applications . New York : Springer 2012 ; 9 – 29 .
17 Nitta SK Numata K. Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering . Int J Mol Sci 2013 ; 14 : 1629 – 54 . 23344060
18 Hotaling NA Tang L Irvine DJ Biomaterial strategies for immunomodulation . Annu Rev Biomed Eng 2015 ; 17 : 371 – 49 .
19 Tian H Tang Z Zhuang X Biodegradable synthetic polymers: preparation, functionalization and biomedical application . Prog Polym Sci 2012 ; 37 : 237 – 80 .
20 Chu C-C. Biodegradable polymers: an overview In: Encyclopedia of Biomaterials and Biomedical Engineering . New York : Informa Healthcare USA, Inc , 2008 , 195 – 206 .
21 Croisier F Jérôme C. Chitosan-based biomaterials for tissue engineering . Eur Polym J 2013 ; 49 : 780 – 92 .
22 Burdick JA Prestwich GD. Hyaluronic acid hydrogels for biomedical applications . Adv Mater 2011 ; 23 : H41 – 56 . 21394792
23 Lee KY Mooney DJ. Alginate: properties and biomedical applications . Prog Polym Sci 2012 ; 37 : 106 – 26 . 22125349
24 Centlivre M Legrand N Klamer S Preclinical in vivo evaluation of the safety of a multi-shRNA-based gene therapy against HIV-1 . Mol Ther Nucl Acids 2013 ; 2 : e120
25 Cavazzana-Calvo M Hacein-Bey S de Saint Basile G Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease . Science 2000 ; 288 : 669 – 72 . 10784449
26 Ashley CE Carnes EC Epler KE Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers . ACS Nano 2012 ; 6 : 2174 – 88 . 22309035
27 Li J Zheng C Cansiz S Self-assembly of DNA nanohydrogels with controllable size and stimuli-responsive property for targeted gene regulation therapy . J Am Chem Soc 2015 ; 137 : 1412 – 5 . 25581100
28 Baum C Kustikova O Modlich U Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors . Hum Gene Ther 2006 ; 17 : 253 – 63 . 16544975
29 Bessis N GarciaCozar F Boissier M. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms . Gene Ther 2004 ; 11 : S10 – S7 . 15454952
30 Thomas CE Ehrhardt A Kay MA. Progress and problems with the use of viral vectors for gene therapy . Nat Rev Genet 2003 ; 4 : 346 – 58 . 12728277
31 Pack DW Hoffman AS Pun S Design and development of polymers for gene delivery . Nat Rev Drug Discov 2005 ; 4 : 581 – 93 . 16052241
32 Mintzer MA Simanek EE. Nonviral vectors for gene delivery . Chem Rev 2008 ; 109 : 259 – 302 . 19053809
33 Guo X Huang L. Recent advances in nonviral vectors for gene delivery . Accounts Chem Res 2011 ; 45 : 971 – 9 .
34 Li L He Z-Y Wei X-W Challenges in CRISPR/CAS9 delivery: potential roles of nonviral vectors . Hum Gene Ther 2015 ; 26 : 452 – 62 . 26176432
35 Whitehead KA Langer R Anderson DG. Knocking down barriers: advances in siRNA delivery . Nat Rev Drug Discov 2009 ; 8 : 129 – 38 . 19180106
36 He Z-Y Wei X-W Luo M Folate-linked lipoplexes for short hairpin RNA targeting Claudin-3 delivery in ovarian cancer xenografts . J Control Release 2013 ; 172 : 679 – 89 . 24144916
37 Hui K Ang P Huang L Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes . Gene Ther 1997 ; 4 : 783 – 90 . 9338006
38 Clements BA Incani V Kucharski C A comparative evaluation of poly-l-lysine-palmitic acid and Lipofectamine™ 2000 for plasmid delivery to bone marrow stromal cells . Biomaterials 2007 ; 28 : 4693 – 704 . 17686514
39 Bikram M Ahn C-H Chae SY. Biodegradable Poly (ethylene glycol)-c o-poly (l-lysine)-g-histidine Multiblock Copolymers for Nonviral Gene Delivery . Macromolecules 2004 ; 37 : 1903 – 16 .
40 Kano A Moriyama K Yamano T Grafting of poly (ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA . J Control Release 2011 ; 149 : 2 – 7 . 20005270
41 Christie RJ Matsumoto Y Miyata K Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection . ACS Nano 2012 ; 6 : 5174 – 89 . 22575090
42 Boussif O Lezoualc’h F Zanta MA. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo : polyethylenimine . Proc Natl Acad Sci 1995 ; 92 : 7297 – 301 . 7638184
43 Kircheis R Wightman L Wagner E. Design and gene delivery activity of modified polyethylenimines . Adv Drug Deliver Rev 2001 ; 53 : 341 – 58 .
44 Kunath K von Harpe A Fischer D Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine . J Control Release 2003 ; 89 : 113 – 25 . 12695067
45 Sawant RR Sriraman SK Navarro G. Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery . Biomaterials 2012 ; 33 : 3942 – 51 . 22365809
46 Zheng M Zhong Y Meng F Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection . Mol Pharm 2011 ; 8 : 2434 – 43 . 21923163
47 Neamnark A Suwantong O KC RB Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression . Mol Pharm 2009 ; 6 : 1798 – 815 . 19719326
48 Merkel OM Beyerle A Librizzi D Nonviral siRNA delivery to the lung: investigation of PEG− PEI polyplexes and their in vivo performance . Mol Pharm 2009 ; 6 : 1246 – 60 . 19606864
49 Liang B He M-L Chan C-Y The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat . Biomaterials 2009 ; 30 : 4014 – 20 . 19427690
50 Cheng H Zhu J-L Zeng X Targeted gene delivery mediated by folate-polyethylenimine-block-poly (ethylene glycol) with receptor selectivity . Bioconjug Chem 2009 ; 20 : 481 – 7 . 19191579
51 Wang M Tucker JD Lu P. Tris [2-(acryloyloxy) ethyl] isocyanurate cross-linked low-molecular-weight polyethylenimine as gene delivery carriers in cell culture and dystrophic mdx mice . Bioconjug Chem 2012 ; 23 : 837 – 45 . 22443086
52 Saito G Swanson JA Lee K-D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities . Adv Drug Deliver Rev 2003 ; 55 : 199 – 215 .
53 Alvarez RD Sill MW Davidson SA A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group Study . Gynecol Oncol 2014 ; 133 : 433 – 8 . 24708919
54 Shah N Steptoe RJ Parekh HS. Low‐generation asymmetric dendrimers exhibit minimal toxicity and effectively complex DNA . J Pept Sci 2011 ; 17 : 470 – 8 . 21351322
55 Biswas S Deshpande PP Navarro G Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery . Biomaterials 2013 ; 34 : 1289 – 301 . 23137395
56 Kim J-B Choi JS Nam K. Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg . J Control Release 2006 ; 114 : 110 – 7 . 16842881
57 Yu T Liu X Bolcato-Bellemin AL An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo . Angew Chem Int Edit 2012 ; 124 : 8606 – 12 .
58 Kwon S Park JH Chung H Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid . Langmuir 2003 ; 19 : 10188 – 93 .
59 Ghosn B Singh A Li M Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA . Oligonucleotides 2010 ; 20 : 163 – 72 . 20565242
60 Wong K Sun G Zhang X PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo . Bioconjug Chem 2006 ; 17 : 152 – 8 . 16417264
61 Keeney M Ong S-G Padilla A Development of Poly (β-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA . ACS Nano 2013 ; 7 : 7241 – 50 . 23837668
62 Zhou J Liu J Cheng CJ. Biodegradable poly (amine-co-ester) terpolymers for targeted gene delivery . Nat Mater 2012 ; 11 : 82 – 90 . 22138789
63 Zhu Y Tang G-P Xu F-J. Efficient poly (N-3-hydroxypropyl) aspartamide-based carriers via ATRP for gene delivery . ACS Appl Mater Interfaces 2013 ; 5 : 1840 – 8 . 23421311
64 Nam HY Nam K Lee M Dendrimer type bio-reducible polymer for efficient gene delivery . J Control Release 2012 ; 160 : 592 – 600 . 22546681
65 Lauring AS Jones JO Andino R. Rationalizing the development of live attenuated virus vaccines . Nat Biotechnol 2010 ; 28 : 573 – 9 . 20531338
66 Leleux J Roy K. Micro and nanoparticle‐based delivery systems for vaccine immunotherapy: an immunological and materials perspective . Adv Healthc Mater 2013 ; 2 : 72 – 94 . 23225517
67 Coffman RL Sher A Seder RA. Vaccine adjuvants: putting innate immunity to work . Immunity 2010 ; 33 : 492 – 503 . 21029960
68 Luo Z Li P Deng J Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy . J Control Release 2013 ; 170 : 259 – 67 . 23742880
69 De Temmerman M-L Rejman J Demeester J Particulate vaccines: on the quest for optimal delivery and immune response . Drug Discov Today 2011 ; 16 : 569 – 82 . 21570475
70 Singh A Peppas NA. Hydrogels and scaffolds for immunomodulation . Adv Mater 2014 ; 26 : 6530 – 41 . 25155610
71 O’Hagan DT De Gregorio E. The path to a successful vaccine adjuvant–‘the long and winding road’ . Drug Discov Today 2009 ; 14 : 541 – 51 . 19508916
72 Foged C Hansen J Agger EM. License to kill: Formulation requirements for optimal priming of CD8+ CTL responses with particulate vaccine delivery systems . Eur J Pharm Sci 2012 ; 45 : 482 – 91 . 21888971
73 Nordly P Madsen HB Nielsen HM. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators . Expert Opin Drug Del 2009 ; 6 : 657 – 72 .
74 Butts C Socinski MA Mitchell PL Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial . Lancet Oncol 2014 ; 15 : 59 – 68 . 24331154
75 Melero I Gaudernack G Gerritsen W Therapeutic vaccines for cancer: an overview of clinical trials . Nat Rev Clin Oncol 2014 ; 11 : 509 – 24 . 25001465
76 De Koker S Lambrecht BN Willart MA. Designing polymeric particles for antigen delivery . Chem Soc Rev 2011 ; 40 : 320 – 39 . 21060941
77 Waeckerle-Men Y Groettrup M. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines . Adv Drug Deliver Rev 2005 ; 57 : 475 – 82 .
78 Fischer S Schlosser E Mueller M Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response . J Drug Target 2009 ; 17 : 652 – 61 . 19622019
79 De Koker S De Geest BG Singh SK Polyelectrolyte microcapsules as antigen delivery vehicles to dendritic cells: uptake, processing, and cross‐presentation of encapsulated antigens . Angew Chem Int Edit 2009 ; 48 : 8485 – 9 .
80 Sexton A Whitney PG Chong S-F A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules . ACS Nano 2009 ; 3 : 3391 – 400 . 19824668
81 Ali OA Huebsch N Cao L Infection-mimicking materials to program dendritic cells in situ . Nat Mater 2009 ; 8 : 151 – 8 . 19136947
82 Bach F Albertini R Joo P Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome . Lancet 1968 ; 292 : 1364 – 6 . 4177931
83 Gatti R Meuwissen H Allen H Immunological reconstitution of sex-linked lymphopenic immunological deficiency . Lancet 1968 ; 292 : 1366 – 9 . 4177932
84 Segers VF Lee RT. Biomaterials to enhance stem cell function in the heart . Circ Res 2011 ; 109 : 910 – 22 . 21960724
85 Magne D Vinatier C Julien M Mesenchymal stem cell therapy to rebuild cartilage . Trends Mol Med 2005 ; 11 : 519 – 26 . 16213191
86 Place ES Evans ND Stevens MM. Complexity in biomaterials for tissue engineering . Nat Mater 2009 ; 8 : 457 – 70 . 19458646
87 Dai W Hale SL Kay GL Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology . Regen Med 2009 ; 4 : 387 – 95 . 19438314
88 Danoviz ME Nakamuta JS Marques F. Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention . PLoS One 2010 ; 5 : e12077 20711471
89 Liu J Hu Q Wang Z. Autologous stem cell transplantation for myocardial repair . Am J Physiol Heart C 2004 ; 287 : H501 – H11 .
90 Lin Y-D Yeh M-L Yang Y-J Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs . Circulation 2010 ; 122 : S132 – S41 . 20837904
91 Wang Y Kim H-J Vunjak-Novakovic G. Stem cell-based tissue engineering with silk biomaterials . Biomaterials 2006 ; 27 : 6064 – 82 . 16890988
92 Dawson E Mapili G Erickson K Biomaterials for stem cell differentiation . Adv Drug Deliver Rev 2008 ; 60 : 215 – 28 .
93 Chai C Leong KW. Biomaterials approach to expand and direct differentiation of stem cells . Mol Ther 2007 ; 15 : 467 – 80 . 17264853
94 Vinatier C Bouffi C Merceron C Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy . Curr Stem Cell Res Ther 2009 ; 4 : 318 19804369
95 Tsubouchi M Matsui S Banno Y. Overview of the clinical application of regenerative medicine products in Japan . Health Policy 2008 ; 88 : 62 – 72 . 18395290
96 Laurencin CT Ambrosio A Borden M Tissue engineering: orthopedic applications . Annu Rev Biomed Eng 1999 ; 1 : 19 – 46 . 11701481
97 Salgado AJ Coutinho OP Reis RL. Bone tissue engineering: state of the art and future trends . Macromol Biosci 2004 ; 4 : 743 – 65 . 15468269
98 Gomes S Leonor IB Mano JF Natural and genetically engineered proteins for tissue engineering . Prog Polym Sci 2012 ; 37 : 1 – 17 . 22058578
99 Dhandayuthapani B Yoshida Y Maekawa T. Polymeric scaffolds in tissue engineering application: a review . Int J Polym Sci 2011 ; 2011 :
100 Khademhosseini A Vacanti JP Langer R. Progress in tissue engineering . Sci Am 2009 ; 300 : 64 – 71 . 19438051
101 Tsang VL Chen AA Cho LM Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels . Faseb J 2007 ; 21 : 790 – 801 . 17197384
102 Möller S Weisser J Bischoff S. Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction . Biomol Eng 2007 ; 24 : 496 – 504 . 17884723
103 Wang T-W Spector M. Development of hyaluronic acid-based scaffolds for brain tissue engineering . Acta Biomater 2009 ; 5 : 2371 – 84 . 19403351
104 Seo S-J Kim I-Y Choi Y-J Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold . Biomaterials 2006 ; 27 : 1487 – 95 . 16188312
105 Fan J Shang Y Yuan Y. Preparation and characterization of chitosan/galactosylated hyaluronic acid scaffolds for primary hepatocytes culture . J Mater Sci Mater Med 2010 ; 21 : 319 – 27 . 19641850
106 Madaghiele M Piccinno A Saponaro M Collagen-and gelatine-based films sealing vascular prostheses: evaluation of the degree of crosslinking for optimal blood impermeability . J Mater Sci Mater Med 2009 ; 20 : 1979 – 89 . 19449199
107 Liu Y Lim J Teoh S-H. Review: development of clinically relevant scaffolds for vascularised bone tissue engineering . Biotechnol Adv 2013 ; 31 : 688 – 705 . 23142624
108 Cao H Kuboyama N. A biodegradable porous composite scaffold of PGA/β-TCP for bone tissue engineering . Bone 2010 ; 46 : 386 – 95 . 19800045
109 Bose S Roy M Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds . Trends Biotechnol 2012 ; 30 : 546 – 54 . 22939815
110 Epstein NE. Pros, cons, and costs of INFUSE in spinal surgery . Surg Neurol Int 2011 ; 2 : 10 21297932
111 Shrivats AR McDermott MC Hollinger JO. Bone tissue engineering: state of the union . Drug Discov Today 2014 ; 19 : 781 – 6 . 24768619
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.